Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGb Group Regulatory News (GBG)

Share Price Information for Gb Group (GBG)

Share Price is delayed by 15 minutes
Get Live Data
198.20    6.40 (3.34%)
Bid:
197.20
Ask:
198.00
Spread: 0.80 (0.406%)
Market Cap: £454.82m
GBG Live PriceLast checked at - London Stock Exchange

Intraday Gb Group Share Chart

Form 8.5 (EPT/RI)

22 Sep 2022 11:19

RNS Number : 3310A
GoldmanSachs International
22 September 2022
Β 

Β 

FORM 8.5 (EPT/RI)

Β 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Name of exempt principal trader:

(GS) GOLDMAN SACHS INTERNATIONAL

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

GB GROUP PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

GB GROUP PLC

(d) Date dealing undertaken:

21 September 2022

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

Β 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchases/ sales

Β 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

2.5p ordinary

Purchases

84,343

6.4100 GBP

6.2893 GBP

2.5p ordinary

Sales

92,326

6.4300 GBP

6.2700 GBP

Β 

Β 

Β 

(b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

2.5p ordinary

CFD

Reducing a short position

5,106

6.3732 GBP

2.5p ordinary

CFD

Reducing a short position

599

6.3732 GBP

2.5p ordinary

CFD

Reducing a short position

73

6.3733 GBP

Β 

Β 

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising / exercised against

Number of securities

Exercise price per unit

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

Β 

3. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

NONE

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

NONE

Β 

Β 

Β 

Date of disclosure:

22 September 2022

Contact name:

Papa Lette and Andrzej Szyszka

Telephone number:

+33(1) 4212 1459 / +48(22) 317 4817

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
FERBGGDCRBDDGDD
Date   Source Headline
29th Jul 20155:20 pmRNSRESULT OF ANNUAL GENERAL MEETING
29th Jul 20157:00 amRNSAGM Statement
17th Jul 20157:00 amRNSBlocklisting Interim Review
30th Jun 20154:01 pmRNSTotal Voting Rights
26th Jun 20153:40 pmRNSNotification of Director's Interest
16th Jun 20155:03 pmRNSHolding(s) in Company
5th Jun 20154:32 pmRNSNotification of Director's Interest
2nd Jun 20153:46 pmRNSDirector/PDMR Shareholding
1st Jun 20157:00 amRNSFinal Results
6th May 20151:16 pmRNSNotice of Results
29th Apr 20151:23 pmRNSHolding(s) in Company
27th Apr 20157:00 amRNSAcquisition of Loqate Inc.
24th Apr 20157:00 amRNSTrading Update
22nd Apr 20153:53 pmRNSForm 8.3 - Royal Dutch Shell Plc - Replacement
7th Apr 20157:00 amRNSPre-Close Trading Statement
1st Apr 20154:06 pmRNSTotal Voting Rights
6th Mar 201510:06 amRNSApplication for Blocklisting
27th Feb 20152:05 pmRNSHolding(s) in Company
27th Feb 20151:15 pmRNSTOTAL VOTING RIGHTS AND SHARE CAPITAL
30th Jan 201510:55 amRNSTotal Voting Rights
19th Jan 20154:25 pmRNSHolding(s) in Company
19th Jan 20157:00 amRNSBlocklisting Interim Review
12th Jan 201510:46 amRNSHolding(s) in Company
31st Dec 201410:00 amRNSTotal Voting Rights
30th Dec 20142:36 pmRNSNotification of Director's Interest
12th Dec 201412:00 pmRNSDirector/PDMR Shareholding
28th Nov 20144:00 pmRNSDirector/PDMR Shareholding
28th Nov 201412:10 pmRNSDirector/PDMR Shareholding
24th Nov 20143:00 pmRNSDirector/PDMR Shareholding
24th Nov 20147:00 amRNSHalf Yearly Report
3rd Nov 20147:00 amRNSCompletion of the Acquisition of CDMS Limited
20th Oct 20147:00 amRNSTrading Update
13th Oct 20149:30 amRNSAcquisition of CDMS Limited
30th Sep 20143:45 pmRNSTotal Voting Rights
22nd Sep 201410:45 amRNSChange of Registered Office
19th Sep 20142:47 pmRNSHolding(s) in Company
5th Sep 20144:15 pmRNSNotification of Directors' Interests
29th Aug 20141:22 pmRNSTotal Voting Rights
12th Aug 20142:45 pmRNSResult of AGM
12th Aug 20147:00 amRNSAGM Statement
31st Jul 20147:00 amRNSTotal Voting Rights And Share Capital
16th Jul 20147:00 amRNSBlocklisting Interim Review
2nd Jul 20147:00 amRNSFinal Results
17th Jun 20142:05 pmRNSNotice of Results
30th May 20147:00 amRNSTotal Voting Rights
2nd May 20144:01 pmRNSDirector/PDMR Shareholding
30th Apr 20145:50 pmRNSTotal Voting Rights
29th Apr 20147:30 amRNSHolding(s) in Company
25th Apr 20145:20 pmRNSHolding(s) in Company
24th Apr 20147:00 amRNSTrading Update, Proposed Acquisition and Placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.